Few drugmakers translate cost cuts into efficiency
Have cost cuts made Big Pharma more efficient? By one financial measure--revenues per dollar of sales and administrative spending--not so much. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.
